Paul Thomas Brinkkoetter (Paul T Brinkkoetter, Paul Brinkkötter)

GND Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Cells

Trials

Journal of thrombosis and haemostasis : JTH

Journal of the American Society of Nephrology : JASN

University Hospital Cologne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Cologne Jan 01 2009

Germany

Attending Physician, Principal Investigator :: Nephrology

Publications

Christoph Heinrich Lindemann, Volker Burst, Linus Alexander Völker, Sebastian Brähler, Dusan Simic, Ingrid Becker, Martin Hellmich, Clarissa Kurscheid, Nadine Scholten, Ruben Krauspe, Kerstin Leibel, Stephanie Stock, Paul Thomas Brinkkoetter
Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial. Trials 25 (1) (2024)
Christoph Heinrich Lindemann, Volker Burst, Linus Alexander Völker, Sebastian Brähler, Dusan Simic, Ingrid Becker, Martin Hellmich, Clarissa Kurscheid, Nadine Scholten, Ruben Krauspe, Kerstin Leibel, Stephanie Stock, Paul Thomas Brinkkoetter
Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial. Trials 25 (1) (2024)
Christoph Heinrich Lindemann, Volker Burst, Linus Alexander Völker, Sebastian Brähler, Dusan Simic, Ingrid Becker, Martin Hellmich, Clarissa Kurscheid, Nadine Scholten, Ruben Krauspe, Kerstin Leibel, Stephanie Stock, Paul Thomas Brinkkoetter
Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial. Trials 25 (1) (2024)
Paul Diefenhardt, Marie Braumann, Thomas Schömig, Bastian Trinsch, Claudio Sierra Gonzalez, Janine Becker-Gotot, Linus A Völker, Lioba Ester, Amrei M Mandel, Daniel Hawiger, Ali T Abdallah, Bernhard Schermer, Heike Göbel, Paul Thomas Brinkkoetter, Christian Kurts, Thomas Benzing, Sebastian Brähler
Stimulation of Immune Checkpoint Molecule B and T-Lymphocyte Attenuator Alleviates Experimental Crescentic Glomerulonephritis. Journal of the American Society of Nephrology : JASN (2023)
Henning Hagmann, Naghmeh Hassanzadeh Khayyat, Mahsa Matin, Cem Oezel, He Chen, Astrid Schauss, Christoph Schell, Thomas Benzing, Stuart Dryer, Paul Thomas Brinkkoetter
Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Cells 12 (2) (2023)
Henning Hagmann, Naghmeh Hassanzadeh Khayyat, Mahsa Matin, Cem Oezel, He Chen, Astrid Schauss, Christoph Schell, Thomas Benzing, Stuart Dryer, Paul Thomas Brinkkoetter
Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Cells 12 (2) (2023)
Henning Hagmann, Naghmeh Hassanzadeh Khayyat, Mahsa Matin, Cem Oezel, He Chen, Astrid Schauss, Christoph Schell, Thomas Benzing, Stuart Dryer, Paul Thomas Brinkkoetter
Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Cells 12 (2) (2023)
Henning Hagmann, Naghmeh Hassanzadeh Khayyat, Mahsa Matin, Cem Oezel, He Chen, Astrid Schauss, Christoph Schell, Thomas Benzing, Stuart Dryer, Paul Thomas Brinkkoetter
Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Cells 12 (2) (2023)
Lucas Kühne, Jessica Kaufeld, Linus A Völker, Ralph Wendt, Ulf Schönermarck, Holger Hägele, Thomas Osterholt, Dennis A Eichenauer, Markus Bieringer, Anke von Bergwelt-Baildon, Michael Fischereder, Veronika Buxhofer-Ausch, Jan Menne, Paul Thomas Brinkkoetter, Paul N Knöbl
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis : JTH 20 (4) (2022)
Henning Hagmann, Naghmeh Hassanzadeh Khayyat, Cem Oezel, Antonios Papadakis, Alexander Kuczkowski, Thomas Benzing, Erich Gulbins, Stuart Dryer, Paul Thomas Brinkkoetter
Paraoxonase 2 (PON2) Deficiency Reproduces Lipid Alterations of Diabetic and Inflammatory Glomerular Disease and Affects TRPC6 Signaling. Cells 11 (22) (2022)
Lucas Kühne, Linus A Völker, Henning Hagmann, Holger Hägele, Thomas Osterholt, Dennis A Eichenauer, Andreas Thomas, Johanna Breuer, Berthold Grüttner, Ingo Gottschalk, Martin Kann, Thomas Benzing, Mario Thevis, Annette M Müller, Paul Thomas Brinkkoetter
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy. British journal of haematology (2021)
Linus A Völker, Paul Thomas Brinkkoetter, Paul N Knöbl, Miroslav Krstic, Jessica Kaufeld, Jan Menne, Veronika Buxhofer-Ausch, Wolfgang Miesbach
Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab. Journal of thrombosis and haemostasis : JTH 18 (11) (2020)

Paul Thomas Brinkkoetter.css-eqlu8i{font-size:small;padding-left:4px;} (Paul T Brinkkoetter, Paul Brinkkötter)

Publication Activity (10 Years)

Top Topics

Top Venues

Paul Thomas Brinkkoetter (Paul T Brinkkoetter, Paul Brinkkötter)